Stanley Capital is a private equity investment firm based in London, United Kingdom, founded in 2019. The firm specializes in pursuing repeatable relative value and thematic investment strategies, focusing on sectors such as technology, healthcare, and sustainability. By targeting businesses within these industries, Stanley Capital aims to drive growth and create value through its investment initiatives across Europe.
SePRO Corporation is a manufacturer specializing in plant protection and management products tailored for various sectors, including aquatics, agriculture, landscape, ornamental, golf, and DIY aquatics. The company develops sustainable agriculture-based specialty chemicals, offering a range of products such as plant growth regulators, herbicides, insecticides, and fungicides. These products are designed to assist professionals in managing invasive weeds and algae in both terrestrial and aquatic environments, thereby supporting effective crop management and environmental sustainability. SePRO's focus on innovation in agricultural chemicals positions it as a key player in the market.
Roboyo
Private Equity Round in 2023
Roboyo GmbH is a prominent automation consulting firm headquartered in Nuremberg, Germany. Founded in 2015, it has rapidly established itself as a leader in hyperautomation professional services, with a presence in 24 cities across 15 countries. The company specializes in intelligent automation consulting, robotic process automation, personal robotic automation, and artificial intelligence solutions. Roboyo serves a diverse range of industries, including industrial manufacturing, banking, insurance, pharmaceuticals, consumer goods, and human resources. Known for its expertise and innovative approach, Roboyo combines strategic vision with technical precision, employing a team of automation engineers, business analysts, and industry specialists. This multidisciplinary team has earned a reputation for delivering effective automation solutions that drive business outcomes for many Fortune 500 companies and a significant number of DAX 40 firms.
Noden Pharma
Acquisition in 2020
Noden Pharma is a global specialty pharmaceutical company dedicated to acquiring and providing prescription medicines across various therapeutic areas. The company holds exclusive worldwide rights to manufacture, market, and sell Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor used for the treatment of hypertension. Noden Pharma aims to enhance the lives of patients by offering effective medical solutions in international markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.